Related Experiment Video
Updated: Jun 4, 2026
06:09
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
Oxidative stress and endothelial dysfunction: therapeutic implications
1II Medizinische Klinik für Kardiologie/Angiologie, University Medical Center of the Johannes Gutenberg University Mainz, Germany. tommaso.gori@unimedizin-mainz.de
Annals of Medicine
|February 3, 2011
Summary
Direct antioxidant therapy for cardiovascular disease has failed in clinical trials, despite preclinical evidence. Medications with indirect antioxidant effects, like statins, show promise for improving cardiovascular outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Oxidative Stress Research
Background:
- Reactive oxygen species (ROS) are implicated in cardiovascular disease (CVD) development and progression.
- Preclinical studies suggest antioxidants benefit endothelial function, but clinical trials show limited efficacy for CVD outcomes.
Purpose of the Study:
- To review the failure of direct antioxidant therapy in cardiovascular disease.
- To explore the success of medications with indirect antioxidant properties in managing CVD.
Main Methods:
- Literature review of preclinical and clinical trial data.
- Analysis of studies on classical antioxidants (vitamin C, E, selenium, folic acid).
- Examination of cardiovascular medications with ancillary antioxidant effects (statins, ACE inhibitors, beta-blockers, ARBs).
Main Results:
- Direct antioxidant therapies have yielded neutral or negative results in large clinical trials for cardiovascular outcomes.
- Medications with indirect antioxidant properties have demonstrated significant benefits in both preclinical and clinical settings for CVD.
Conclusions:
- The direct administration of classical antioxidants is ineffective for improving cardiovascular prognosis.
- Therapies with indirect antioxidant mechanisms represent a more successful strategy for managing cardiovascular disease.
More Related Videos
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation